Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck
Xconomy
NOVEMBER 13, 2019
Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Let's personalize your content